Skip to contentS
Strata Critical Medical, Inc.
S
SRTAStrata Critical Medical, Inc. Q2 2026 · 10-Q
Revenue$72.51M$72.51M+60.7% vs Q2 2025 Net Income-$10.52M-$10.52MN/M vs Q2 2025 EPS Diluted-$0.12-$0.12N/M vs Q2 2025 Gross Profit$15,215,000+68.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
Operating Cash Flowderived$5,687,000N/M Free Cash Flowderived$3,197,000N/M Margins · derivedGross margin21.0%+1.0 pt vs Q2 2025
Operating margin-7.5%+2.8 pt vs Q2 2025
Net margin-14.5%−6.2 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 4, 2026 · 35 d after period end